đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The objective of the study is to evaluate the efficacy and tolerability of ...
Status
Completed
Location
Centre nÂș 101
Start Date
2006-07
Trial ID
NCT00421109
Treatments Being Tested
Brief Summary - OMENUTS Trial Otitis media with effusion (OME) is a conditi...
Status
Completed
Location
Isola Tiberina - Gemelli Isola Hospital Rome, Italy
Start Date
2025-10-01
Trial ID
NCT07721610
To evaluate the efficacy of Bilastine ophthalmic solution 0.6% compared to ...
Status
Completed
Location
Cornea Consultants of AZ
Start Date
2018-04-07
Trial ID
NCT03479307
This is a single-dose and multiple-dose, open-label, single-centre pharmaco...
Status
Unknown
Location
Phase I Clinical Trial Centre, Chinese University of Hong Kong
Start Date
2018-08-28
Trial ID
NCT03633760
Treatments Being Tested
To evaluate the efficacy of Bilastine Ophthalmic Solution (0.2%,0.4%,0.6%) ...
Status
Completed
Location
Ora Clinical Research Center
Start Date
2017-07-20
Trial ID
NCT03231969
Treatments Being Tested
The purpose of this study is to assess the absolute bioavailability of an o...
Status
Completed
Location
Unidad de Investigacion Clinica. Clinica Universidad de Navarra
Start Date
2010-05
Trial ID
NCT01124123
The objective of the study was to determine the efficacy and tolerability o...
Status
Completed
Location
Yonsei University college of Medicine, Gangnam Severance Hospital
Start Date
2011-06
Trial ID
NCT01400828
Treatments Being Tested
The aim of the study is to evaluate the effects of Bilastine on patients' a...
Status
Completed
Location
Azienda Ospedaliero-Universitaria Policlinico
Start Date
2015-10
Trial ID
NCT02576041